$IBB Company News Tekmira CEO says being a biotech is

New Post Public Reply Private Reply Replies (0) Message Board

Oct 11, 2014 at 1:18 PM

$IBB Company News

Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 8:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Charting the October technical breakdown 11:06 a.m. Oct. 2, 2014 - Michael Ashbaugh
Charting the S&P 500’s precarious posture 10:44 a.m. Sept. 25, 2014 - Michael Ashbaugh
Nasdaq balks at the September peak 10:40 a.m. Sept. 22, 2014 - Michael Ashbaugh
U.S. stocks end lower; tech and small-caps lead losses 4:09 p.m. Sept. 15, 2014 - Anora Mahmudova
Stock-picking gains traction as volatility looms 6:01 a.m. Sept. 7, 2014 - Wallace Witkowski
S&P clears the 2,000 mark, reaches uncharted territory 11:49 a.m. Aug. 26, 2014 - Michael Ashbaugh
S&P clears the 2,000 mark, reaches uncharted territory 11:35 a.m. Aug. 26, 2014 - Michael Ashbaugh
This one stock sector can withstand all the ‘bubble’ talk 6:01 a.m. Aug. 21, 2014 - Jeff Reeves
S&P 500 retests the breakdown point 11:17 a.m. Aug. 14, 2014 - Michael Ashbaugh
U.S. stocks push higher; biotechs rally 4:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Dow, S&P 500 inch up, while Nasdaq, Russell 2000 slip: stock market live blog recap 3:34 p.m. July 28, 2014 - blogs.marketwatch.com
Momentum plays stabilize: Biotech, social-media stocks rally in the past week 5:52 p.m. July 25, 2014 - blogs.marketwatch.com
Stocks bounce back Friday, end with gains for the week: live blog recap 3:21 p.m. July 18, 2014 - blogs.marketwatch.com
Another bear market for froth stocks? 3:03 p.m. July 17, 2014 - John Nyaradi
U.S. stocks gain; Dow sets its 15th record of the year 4:03 p.m. July 16, 2014 - Anora Mahmudova
U.S. stocks close lower; Dow ekes out a gain 4:17 p.m. July 15, 2014 - Anora Mahmudova
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Social-media and biotech stocks weaker after Fed warning 10:23 a.m. July 15, 2014 - Steve Goldstein
U.S. stocks fall; momentum plays hit hard 4:21 p.m. July 8, 2014 - Anora Mahmudova

Amgen spin-out on deck for IPO 11:29 a.m. Oct. 10, 2014 - Seeking Alpha
Ebola vaccine trial commences in Mali 4:08 p.m. Oct. 9, 2014 - Seeking Alpha
Great Basin prices IPO 8:13 a.m. Oct. 9, 2014 - Seeking Alpha
'Fast Money' Recap: Relief About the Stock Market Rally 5:00 a.m. Oct. 9, 2014 - TheStreet.com
Market Scores Key Reversal Day, but More Work to be Done 9:54 p.m. Oct. 8, 2014 - InvestorPlace.com
U.S. to implement Ebola screening at airports 7:19 a.m. Oct. 8, 2014 - Seeking Alpha
'Fast Money' Recap: What Should You Buy in a Declining Market? 5:00 a.m. Oct. 8, 2014 - TheStreet.com
Was Friday’s Rally Just a Dead Cat Bounce? 9:13 p.m. Oct. 5, 2014 - InvestorPlace.com
Israeli Biotech Stocks Offer Low Returns For High Risk Investment 8:12 a.m. Oct. 3, 2014 - Seeking Alpha
Kite heads north as investors pile in after CNBC highlights analyst's call 4:50 p.m. Oct. 2, 2014 - Seeking Alpha
NeuroSigma on deck for IPO 1:15 p.m. Oct. 2, 2014 - Seeking Alpha
The Complete Guide to Biotech ETFs - ETF News And Commentary 12:09 p.m. Oct. 2, 2014 - Zacks.com
FDA publishes guidance on med device cybersecurity 10:05 a.m. Oct. 1, 2014 - Seeking Alpha
Big money flowing to from med firms to docs 8:21 a.m. Oct. 1, 2014 - Seeking Alpha
Dermira on tap for IPO 4:52 p.m. Sept. 30, 2014 - Seeking Alpha
Diplomat Pharmacy on deck for IPO 1:34 p.m. Sept. 30, 2014 - Seeking Alpha
Calithera Biosciences on deck for IPO 1:11 p.m. Sept. 30, 2014 - Seeking Alpha
I Agree With Yellen, Sell Biotech Right Now 1:52 p.m. Sept. 27, 2014 - Seeking Alpha
3 Innovative Biotech Stocks to Diversify Your Portfolio 8:50 a.m. Sept. 26, 2014 - InvestorPlace.com
'Fast Money' Recap: How to Trade After the Market's Drop 5:00 a.m. Sept. 26, 2014 - TheStreet.com

Premier Biomedical Advances Technology via Partnerships 10:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 9:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 9:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 9:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 6:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 8:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 8:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 8:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 12:06 p.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 8:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 8:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 8:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 8:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 9:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 8:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 8:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 8:52 a.m. July 17, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fidelis Care Opens $120K Workforce Grants for Aid

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Long March Reflections: Lesson of Adaptation Endures

Ever stood in a place where history feels so heavy you can almost touch it? That's Lazikou, a gorge in southern Gansu, where ninety years ago, young soldiers of China's Red Army faced a seemingly impassable barrier. Yet, they managed to climb, transform a military retreat into legend, and essentially shape the nation's path ahead. It's a feat that still sends ripples...

Firehawk Defense Secures $150M, Valuation Hits $1.4B

Firehawk Defense Lands Major Funding Think about it—Firehawk Defense, a gutsy Dallas-based new-kid-on-the-block, just snagged a whopping $150 million in fresh funding. The news? Their valuation's now sitting pretty at $1.4 billion. Not peanuts, by any means. For a company in the artillery game, that's a blast of an announcement. They're predicting they'll become the big...

Vertiv's Explosive Q3 Growth: A 2026 Power Move

Vertiv's Third Quarter Triumph Imagine a company blowing past expectations like a hot knife through butter—yeah, that's Vertiv for you in 2026. These guys didn’t just ride the wave; they created a tsunami in the digital infrastructure sector. Net sales ballooned by a staggering 61% compared to last year's same quarter, pulling in $4.313 billion. When you consider the...

Amgen Q3 2026 Results: What Investors Should Know

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

2026 Data Integration Stars: User Sentiments Revealed

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Right College Fit Crucial for Graduation Rates

Navigating College Choices: More Than Just a Hunch When it comes to picking the right college, a lot of folks think it's like shooting in the dark—it's more than just a blind dart throw at a life map. According to a new report from the College Board, aligning with the right academic institution isn't merely a nice-to-have deal; it fundamentally shifts the odds in favor...

GeoComm and Rypplzz Team Up for 3D Mapping Breakthrough

Cracking the Mystery of Multilevel Locations Let me tell you, when lives hang in the balance, every second counts. We've all seen the chaos when first responders are trying to pinpoint someone's location inside a building with more floors than a loaf of bread. Enter GeoComm and Rypplzz, the new superheroes in this story. These two companies have realized the opportunity...

Probiotics in Animal Feed: Market Reaches $8.76B by 2031

Let's cut straight to the chase: the probiotics in animal feed market is steaming ahead, set to grow from a respectable $5.82 billion in 2026 to a hearty $8.76 billion by 2031. We're talking about a solid CAGR of 8.5% here. Now that's the kind of growth trajectory that gets even the most jaded traders sitting up and taking notice. Big Numbers in Livestock Nutrition...

JELD-WEN Kicks Off 2027 Senior Notes Exchange

A Fresh Play: Swapping Old for New With a fresh brew in hand and the latest company maneuvers on the table, JELD-WEN's move to exchange its 4.875% Senior Notes due 2027 for new secured notes maturing in 2031 comes into focus. This ain't just some routine shuffling of papers. They're calling up eligible folks holding onto those old notes, saying, 'Why stick with the old...